PT - JOURNAL ARTICLE AU - Gountas Ilias AU - Hillas Georgios AU - Souliotis Kyriakos TI - Act early, save lives: managing COVID-19 in Greece AID - 10.1101/2020.04.29.20084798 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.29.20084798 4099 - http://medrxiv.org/content/early/2020/05/02/2020.04.29.20084798.short 4100 - http://medrxiv.org/content/early/2020/05/02/2020.04.29.20084798.full AB - Objectives To assess the impact of the implemented social distancing interventions (SD) in Greece.Study Design A dynamic, discrete time, stochastic individual-based model was developed to simulate COVID-19 transmission.Methods We fit the transmission model to the observed trends in deaths and ICU beds use.Results If Greece had not implemented the SD measures, the healthcare system would have been overwhelmed between 30 March and 4 of April. Additionally, the SD interventions averted 4360 deaths and prevent the healthcare system from overwhelmed.Conclusions The fast reflexes of the Greek government limit the burden of the Covid-19 outbreak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is co-financed by Greece and the European Union (European Social Fund- ESF) through the Operational Programme Â≪Human Resources Development, Education and Lifelong LearningÂ≫ in the context of the project âЄœReinforcement of Postdoctoral Researchers - 2nd CycleâЄ (MIS-5033021), implemented by the State Scholarships Foundation (IKY)Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the paper